Research Article
Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
Table 4
Coronary artery lesions in the two groups.
| | Follow-up time | Group 1 (n = 141) | Group 2 (n = 1140) | X2 | value | | Dilation | SCAA | MCAA | GCAA | Dilation | SCAA | MCAA | GCAA | CALs | CALs |
| | Initial echo at diagnosis | 35 (24.8) | 17 (12.1) | 5 (3.5) | 4 (2.8) | 210 (18.4) | 45 (3.9) | 15 (1.3) | 8 (0.7) | 22.975 | <0.001 | | 1 month | 25 (17.7) | 11 (7.8) | 5 (3.5) | 6 (4.3) | 119 (10.4) | 22 (1.9) | 11 (1.0) | 7 (0.6) | 54.217 | <0.001 | | 3 months | 12 (8.5) | 6 (4.3) | 4 (2.8) | 6 (4.3) | 45 (3.9) | 10 (0.9) | 7 (0.6) | 8 (0.7) | 33.422 | <0.001 | | 6 months | 7 (5.0) | 5 (3.5) | 5 (3.5) | 3 (2.1) | 13 (1.1) | 11 (1.0) | 6 (0.5) | 6 (0.5) | 36.494 | <0.001 | | 12 months | 4 (2.8) | 5 (3.5) | 3 (2.1) | 2 (1.4) | 12 (1.1) | 4 (0.4) | 3 (0.3) | 6 (0.5) | 25.441 | <0.001 |
|
|
Data are expressed as numbers (percentage). SCAA, small coronary artery aneurysm; MCAA, medium coronary artery aneurysm; GCAA, giant coronary artery aneurysm; CALs, coronary artery lesions = dilation + SCAA + MCAA + GCAA.
|
